Demonstrating EVERSANA’s commitment to innovation, a new artificial intelligence technology aims to improve NAVLIN for both existing and new customers.
Digital technologies are transforming the pharmaceutical industry's ability to meet the evolving needs of healthcare professionals (HCPs) and patients.
The global pharmaceutical industry is witnessing a surge in innovation, with the industry experiencing a 5% growth in the number of AI-related patent applications in Q1 2024 and
With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharm
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
